Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Journal of Cancer Research and Clinical Oncology
|
January 1, 1997
The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinoma
G G Steger, M F Gnant, M P Djavanmard, et al.
Cancer Research
|
July 1, 1997
5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients
M Müller, R M Mader, B Steiner, et al.
International Archives of Occupational and Environmental Health
|
November 1, 2000
Long-term monitoring of sister chromatid exchanges and micronucleus frequencies in pharmacy personnel occupationally exposed to cytostatic drugs
A Pilger, I Köhler, H Stettner, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research
|
December 14, 2007
Monitoring, removal and risk assessment of cytostatic drugs in hospital wastewater
K Lenz, S N Mahnik, N Weissenbacher, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
December 2, 2004
Cytotoxic and apoptotic effects of novel heterodinucleoside phosphates consisting of 5-fluorodeoxyuridine and Ara-C in human cancer cell lines
P Saiko, W Bauer, Z Horvath, et al.
British Journal of Haematology
|
November 11, 1999
Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disorders
G J Locker, S Kapiotis, M Veitl, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 25, 1999
Negative chronotropic effects of fentanyl attenuate beneficial effects of dobutamine on oxygen metabolism: hemodynamic and pharmacokinetic interactions
G J Locker, R M Mader, B Rizovski, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
March 16, 2006
Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC
S Maier, S Strasser, P Saiko, et al.
British Journal of Cancer
|
December 1, 2011
Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases
R Bartsch, A Berghoff, U Pluschnig, et al.
Breast Cancer Research and Treatment
|
April 25, 2016
Prognostic impact of breast cancer subtypes in elderly patients
E S Bergen, C Tichy, A S Berghoff, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Journal of Cancer Research and Clinical Oncology
|
January 1, 1997
The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinoma
G G Steger, M F Gnant, M P Djavanmard, et al.
Cancer Research
|
July 1, 1997
5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients
M Müller, R M Mader, B Steiner, et al.
International Archives of Occupational and Environmental Health
|
November 1, 2000
Long-term monitoring of sister chromatid exchanges and micronucleus frequencies in pharmacy personnel occupationally exposed to cytostatic drugs
A Pilger, I Köhler, H Stettner, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research
|
December 14, 2007
Monitoring, removal and risk assessment of cytostatic drugs in hospital wastewater
K Lenz, S N Mahnik, N Weissenbacher, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
December 2, 2004
Cytotoxic and apoptotic effects of novel heterodinucleoside phosphates consisting of 5-fluorodeoxyuridine and Ara-C in human cancer cell lines
P Saiko, W Bauer, Z Horvath, et al.
British Journal of Haematology
|
November 11, 1999
Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disorders
G J Locker, S Kapiotis, M Veitl, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 25, 1999
Negative chronotropic effects of fentanyl attenuate beneficial effects of dobutamine on oxygen metabolism: hemodynamic and pharmacokinetic interactions
G J Locker, R M Mader, B Rizovski, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
March 16, 2006
Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC
S Maier, S Strasser, P Saiko, et al.
British Journal of Cancer
|
December 1, 2011
Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases
R Bartsch, A Berghoff, U Pluschnig, et al.
Breast Cancer Research and Treatment
|
April 25, 2016
Prognostic impact of breast cancer subtypes in elderly patients
E S Bergen, C Tichy, A S Berghoff, et al.
Page
of 5